Activities

Targeting the Immune System in Head and Neck Squamous-Cell Carcinoma
James J. Natale, PharmD, BCOP
Credit hours: 1.0

Updates on the Management of Metastatic Colorectal Cancer
J. Aubrey Waddell, PharmD, FAPhA, BCOP
Credit hours: 0.5

Implications in Managed Care for the Treatment of Melanoma and NSCLC
Val R. Adams, PharmD, FCCP, BCOP and Patrick Medina, PharmD, BCOP
Credit hours: 1.5

Targeted Therapies in Non-Small Cell Lung Cancer: An Update for Pharmacists
R. Donald Harvey, PharmD, FCCP, BCOP
Credit hours: 0.5

Lysis Crisis: Pharmacist's Role and Responsibility in the Management of Tumor Lysis Syndrome
LeAnne Kennedy, PharmD, BCOP, CPP
Credit hours: 1.0

Tyrosine Kinase Inhibitors: Updates on the use in Differentiated Thyroid Cancer, Renal Cell Carcinoma, and Gastrointestinal Stromal Tumor
Kelley D. Carlstrom, PharmD, BCOP
Credit hours: 0.5

Testing to Target Non-Small Cell Lung Cancer: Managed Care Perspectives
R. Donald Harvey, PharmD, FCCP, BCOP
Credit hours: 1.5

Immunotherapy for Metastatic Renal Cell Carcinoma: Novel Treatment Strategies
R. Donald Harvey, PharmD, FCCP, BCOP
Credit hours: 1.0

Updates on the Management of Prostate Cancer
J. Aubrey Waddell, PharmD, FAPhA, BCOP
Credit hours: 0.5

Targeted Biologic Therapies in Gastroesophageal Junction Cancer
James J. Natale, PharmD, BCOP
Credit hours: 0.5

Metastatic Colorrectal Cancer: Targeting What Pharmacists Need to Know
Jane E. Rogers, PharmD, BCOP and Matthew Farber
Credit hours: 1.5

New and Emerging Immuno-Therapy Treatment Options in Oncology
R. Donald Harvey, PharmD, FCCP, BCOP
Credit hours: 1.0

New and Emerging Immuno-Therapy Treatment Options in Oncology
R. Donald Harvey, PharmD, FCCP, BCOP
Credit hours: 1.0

Expanding Horizons in Immuno-Oncology: Health-System Pharmacists’ Perspectives
Val R. Adams, PharmD, FCCP, BCOP
Credit hours: 0.5

© Oncology RX Consults 2016

;